[go: up one dir, main page]

DK1259240T3 - Midler, såsom nikotinamid eller CADPR, til behandling af hudsygdomme - Google Patents

Midler, såsom nikotinamid eller CADPR, til behandling af hudsygdomme

Info

Publication number
DK1259240T3
DK1259240T3 DK01900231T DK01900231T DK1259240T3 DK 1259240 T3 DK1259240 T3 DK 1259240T3 DK 01900231 T DK01900231 T DK 01900231T DK 01900231 T DK01900231 T DK 01900231T DK 1259240 T3 DK1259240 T3 DK 1259240T3
Authority
DK
Denmark
Prior art keywords
cadpr
nicotinamide
treatment
agents
skin diseases
Prior art date
Application number
DK01900231T
Other languages
English (en)
Inventor
Ltd Dermipsor
Original Assignee
Ltd Dermipsor
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ltd Dermipsor filed Critical Ltd Dermipsor
Application granted granted Critical
Publication of DK1259240T3 publication Critical patent/DK1259240T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60Sugars; Derivatives thereof
    • A61K8/606Nucleosides; Nucleotides; Nucleic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7076Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67Vitamins
    • A61K8/673Vitamin B group
    • A61K8/675Vitamin B3 or vitamin B3 active, e.g. nicotinamide, nicotinic acid, nicotinyl aldehyde
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/08Anti-ageing preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
DK01900231T 2000-01-11 2001-01-09 Midler, såsom nikotinamid eller CADPR, til behandling af hudsygdomme DK1259240T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL133976A IL133976A (en) 2000-01-11 2000-01-11 Agents for the treatment of skin disorders

Publications (1)

Publication Number Publication Date
DK1259240T3 true DK1259240T3 (da) 2006-10-30

Family

ID=11073692

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01900231T DK1259240T3 (da) 2000-01-11 2001-01-09 Midler, såsom nikotinamid eller CADPR, til behandling af hudsygdomme

Country Status (11)

Country Link
US (1) US20030032617A1 (da)
EP (1) EP1259240B8 (da)
AT (1) ATE332136T1 (da)
AU (1) AU782558B2 (da)
CA (1) CA2396186C (da)
DE (1) DE60121303T2 (da)
DK (1) DK1259240T3 (da)
ES (1) ES2267706T3 (da)
HK (1) HK1051497A1 (da)
IL (2) IL133976A (da)
WO (1) WO2001051051A2 (da)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006120682A2 (en) 2005-05-10 2006-11-16 Dermipsor Ltd. Compositions and methods for treating hyperproliferative epidermal diseases
US20090098065A1 (en) * 2000-01-11 2009-04-16 Avikam Harel Composition and methods for the treatment of skin disorders
WO2003001985A2 (en) * 2001-06-28 2003-01-09 Dermtech International Method for detection of melanoma
PT1560589E (pt) 2002-06-20 2007-01-31 Astion Dermatology As Novos complexos de ésteres de ácidos gordos de polihidroxialcanos e niacinamida
CA2492248A1 (en) * 2002-07-11 2004-01-22 Avikam Harel Composition and methods for the treatment of skin disorders
US7357950B2 (en) 2003-03-21 2008-04-15 Elizabeth Anne Mazzio Topical treatment for dyshidrosis (pompholyx) and dry skin disorders
US7666451B2 (en) 2003-03-21 2010-02-23 Elizabeth Anne Mazzio Method of treating dyshidrosis(pompholyx) and related dry skin disorders
GB0403041D0 (en) 2004-02-11 2004-03-17 Milner Anne J Induction of apoptosis
US7183057B2 (en) * 2004-03-31 2007-02-27 Dermtech International Tape stripping methods for analysis of skin disease and pathological skin state
CN101217868A (zh) 2005-05-10 2008-07-09 德米普瑟尔有限公司 用于皮肤护理的组合物和方法
US20070183995A1 (en) * 2006-02-09 2007-08-09 Conopco, Inc., D/B/A Unilever Compounds useful as agonists of A2A adenosine receptors, cosmetic compositions with A2A agonists and a method for using the same
GB0619860D0 (en) * 2006-10-06 2006-11-15 Birkeland Innovasjon As Treatment of insulin resistance and disorders associated therewith
US20080173558A1 (en) * 2007-01-22 2008-07-24 Contelanea Arvanitis Fragrance-emanating nasal mask device and method
CA2686212A1 (en) * 2007-05-04 2008-11-13 Dermtech International Diagnosis of melanoma by nucleic acid analysis
EP2626437A3 (en) 2008-05-14 2013-12-11 Dermtech International Diagnosis of melanoma and solar lentigo by nucleic acid analysis
EP2331707A4 (en) * 2008-08-28 2012-06-06 Dermtech Int DETERMINATION OF THE AGING RANGE OF SKIN SAMPLE
US20160317419A1 (en) * 2015-05-01 2016-11-03 The Procter & Gamble Company Method of improving skin health and compositions therefor
WO2017004102A1 (en) 2015-06-29 2017-01-05 The Procter & Gamble Company Multi-component skin care product comprising nicoinamide riboside in a multi-chambered container
WO2017123512A1 (en) 2016-01-11 2017-07-20 The Procter & Gamble Company Method of treating a skin condition and compositions therefor
CN110785161B (zh) 2017-06-23 2023-06-20 宝洁公司 用于改善皮肤外观的组合物和方法
AU2019222462A1 (en) 2018-02-14 2020-09-03 Dermtech, Inc. Novel gene classifiers and uses thereof in non-melanoma skin cancers
KR102069088B1 (ko) * 2018-04-02 2020-01-22 양미경 탈모의 예방 또는 치료용, 또는 발모 또는 육모 촉진용 약학 또는 화장료 조성물
WO2020010036A1 (en) 2018-07-03 2020-01-09 The Procter & Gamble Company Method of treating a skin condition
JP2022524641A (ja) 2019-03-26 2022-05-09 ダームテック,インク. 皮膚癌における新規な遺伝子分類子とその使用
US11685766B2 (en) 2019-05-08 2023-06-27 Creighton University 14-3-3 targeting peptides for cancer treatment
WO2020227625A1 (en) * 2019-05-08 2020-11-12 Laura Hansen 14-3-3 targeting peptides for cancer treatment
US10959933B1 (en) 2020-06-01 2021-03-30 The Procter & Gamble Company Low pH skin care composition and methods of using the same
WO2021247496A1 (en) 2020-06-01 2021-12-09 The Procter & Gamble Company Method of improving penetration of a vitamin b3 compound into skin

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4067975A (en) * 1975-08-04 1978-01-10 Yu Ruey J Treatment of psoriasis with 6-aminonicotinamide and thionicotinamide
US4505896A (en) * 1979-04-19 1985-03-19 Elorac, Ltd. Method of treating acne vulgaris and composition
HU209067B (en) * 1991-12-30 1994-03-28 Tatar Process for the production of hair-fall moderating preparation
DE4335454A1 (de) * 1993-10-19 1995-04-20 Schleicher Peter Geriatrikum
US6248763B1 (en) * 1998-05-19 2001-06-19 Scivoletto Rosemarie Composition for treating skin conditions
US6429218B1 (en) * 1997-05-19 2002-08-06 Joseph Scivoletto Method of controlling niacin concentration in lotion
USH2013H1 (en) * 1997-05-23 2002-02-05 The Procter & Gamble Company Skin care compositions
US6107349A (en) * 1998-04-16 2000-08-22 Mantynen; Philip R. Method and composition for treating psoriasis
DE29916231U1 (de) * 1999-09-15 2000-02-17 Renner, Jobst, Dr., 81479 München Multivitamin- und -mineralpräparat

Also Published As

Publication number Publication date
IL150706A0 (en) 2003-02-12
ATE332136T1 (de) 2006-07-15
WO2001051051A3 (en) 2002-06-27
EP1259240A2 (en) 2002-11-27
WO2001051051B1 (en) 2002-09-26
IL133976A0 (en) 2001-04-30
EP1259240B1 (en) 2006-07-05
WO2001051051A2 (en) 2001-07-19
HK1051497A1 (en) 2003-08-08
US20030032617A1 (en) 2003-02-13
AU2392901A (en) 2001-07-24
DE60121303T2 (de) 2007-06-14
IL133976A (en) 2006-09-05
AU782558B2 (en) 2005-08-11
CA2396186A1 (en) 2001-07-19
CA2396186C (en) 2011-03-22
ES2267706T3 (es) 2007-03-16
DE60121303D1 (de) 2006-08-17
EP1259240B8 (en) 2007-05-09

Similar Documents

Publication Publication Date Title
DK1259240T3 (da) Midler, såsom nikotinamid eller CADPR, til behandling af hudsygdomme
EE200300033A (et) Tsüklopentanoindoolid, nende kasutamine ravimi valmistamiseks ning neid sisaldav farmatseutiline kompositsioon
MY143795A (en) Tetrahydropyridoindole derivatives
BR0214343A (pt) Inibidores de 11 - beta - hidroxi esteróide desidrogenase tipo 1
PT1119543E (pt) N-aralquilaminotetralinas como ligandos para o receptor y5 do neuropeptido y
MY144992A (en) Substituted 1,2,3,4-tetrahydroisoquinoline derivatives.
MY129263A (en) Vaccine composition
DK1289517T3 (da) Farmaceutiske sammensætninger indeholdende cannabidiolderivater
HK1057752A1 (en) N-phenyl-2-pyrimidine-amine derivatives
IL154888A (en) Aqueous Pharmaceutical Gel Preparation Containing At least One Vitamin D or One Vitamin D Analog At least One Corticosteroid
BG66093B1 (bg) Състави с контролирано освобождаване, съдържащи нимесулид
DK0781281T3 (da) Beta-Carbolinderivater som melatonin-agonister, fremgangsmåder til fremstilling deraf og deres anvendelse som lægemiddel
DE60019334D1 (de) Antivirale arznei
IL150953A0 (en) A composition comprising camptothecin and a pyrimidine derivative for the treatment of cancer
DK1303278T3 (da) Kombination af et transdermalt terapeutisk system og et oralt og/eller parenteralt præparat indeholdende dopaminagonister til behandling af dopaminerge sygdomme
MXPA04001256A (es) Productos de combinacion de derivados de propanolamina aril substituidos con otros ingredientes activos y su uso.
BR0113165A (pt) Derivados de 4-pirimidinamina, composições farmacêuticas e métodos relacionados
TNSN07203A1 (en) Pharmaceutical compositions for the treatment of cellulite
PA8525801A1 (es) Compuestos de pirazol, composiciones farmacéuticas, y métodos para modular y/o inhibir la actividad de erab/hadh2
EE200300129A (et) Distamütsiini alfa-halogenoakrüloüülderivaadi kasutamine
WO2004006887A3 (en) Composition and methods for the treatment of skin disorders
SE0001916D0 (sv) Novel formulation
AR035988A1 (es) Derivados de pirrolo-(3,4-b)quinoleina, su procedimiento de preparacion y su uso para la preparacion de medicamento
SE0203817D0 (sv) New composition
DK1227826T3 (da) Sammensætninger omfattende et ekstrakt af Perna canaliculus, methylsulfonylmethan og glucosamid samt anvendelsen heraf